Viromed Medical AG completes acquisition of pharmedix GmbH

Viromed Medical AG / Key word(s): Takeover/Mergers & Acquisitions
Viromed Medical AG completes acquisition of pharmedix GmbH

20-Dec-2024 / 14:05 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Viromed Medical AG completes acquisition of pharmedix GmbH

• Notarial purchase agreement signed today
• Consolidated revenues are expected to multiply to a low double-digit million euro amount in fiscal year 2025.

Pinneberg, 20 December 2024 – Today, Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) completed the announced acquisition of pharmedix GmbH by notarized purchase agreement. The acquisition is effective as of 1 January 2025. Following the successful acquisition of pharmedix GmbH, Viromed Medical AG now expects consolidated revenues in the low double-digit million euro range for the 2025 financial year, a significant increase over the previous year.

Contact Viromed Medical AG

Uwe Perbandt
CEO
Flensburger Straße 18
25421 Pinneberg
E-Mail: kontakt@viromed-medical.de
www.viromed-medical-ag.de

20-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com